Prevent aortic complications in patients with Marfan's syndrome by targeting the underlying histological and haemodynamic abnormalities

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.2, 2008-02, pp. : 8-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perindopril effective for aortic abnormalities in Marfan syndrome

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Cardiovascular Pharmacotherapy in Patients with Marfan Syndrome

By Yetman Anji T.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 2, 2007-01 ,pp. : 117-126

Adis International

Access to resources Recommend Favorite

Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections

By  

Current Pharmaceutical Design, Vol. 21, Iss. 28, 2015-08 ,pp. : 4061-4075

Bentham Science Publishers

Access to resources Recommend Favorite

Underlying karyotype abnormalities in IVF/ICSI patients

By Chantot-Bastaraud S   Ravel C   Siffroi JP  

Reproductive BioMedicine Online, Vol. 16, Iss. 4, 2008-04 ,pp. : 514-522

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Assess underlying risks when choosing a treatment to prevent strokes in patients with atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 7, 2011-07 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite